These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 21459958

  • 21. Allergic pancytopenia to trimethoprim-sulphamethoxazole for Pneumocystis carinii pneumonia following methotrexate treatment for rheumatoid arthritis.
    Chevrel G, Brantus JF, Sainte-Laudy J, Miossec P.
    Rheumatology (Oxford); 1999 May; 38(5):475-6. PubMed ID: 10371291
    [No Abstract] [Full Text] [Related]

  • 22. Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients.
    Komano Y, Harigai M, Koike R, Sugiyama H, Ogawa J, Saito K, Sekiguchi N, Inoo M, Onishi I, Ohashi H, Amamoto F, Miyata M, Ohtsubo H, Hiramatsu K, Iwamoto M, Minota S, Matsuoka N, Kageyama G, Imaizumi K, Tokuda H, Okochi Y, Kudo K, Tanaka Y, Takeuchi T, Miyasaka N.
    Arthritis Rheum; 2009 Mar 15; 61(3):305-12. PubMed ID: 19248121
    [Abstract] [Full Text] [Related]

  • 23. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
    Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A.
    Clin Transplant; 2012 Mar 15; 26(3):E184-90. PubMed ID: 22487221
    [Abstract] [Full Text] [Related]

  • 24. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis jiroveci infection in orthotopic liver transplantation.
    Almaslmani M, Derbala MF, Albozom I, Khattab M, Chacko K, Alani A.
    Transpl Infect Dis; 2008 Oct 15; 10(5):339-42. PubMed ID: 18248564
    [Abstract] [Full Text] [Related]

  • 25. Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole.
    Yukawa K, Nagamoto Y, Watanabe H, Funaki M, Iwahashi M, Yamana J, Sasaki R, Yamana S.
    J Clin Rheumatol; 2018 Oct 15; 24(7):355-360. PubMed ID: 29664819
    [Abstract] [Full Text] [Related]

  • 26. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
    Fisk M, Sage EK, Edwards SG, Cartledge JD, Miller RF.
    Int J STD AIDS; 2009 Sep 15; 20(9):652-3. PubMed ID: 19710343
    [Abstract] [Full Text] [Related]

  • 27. Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP).
    Blanchet KD.
    AIDS Patient Care STDS; 1996 Apr 15; 10(2):116-21. PubMed ID: 11361688
    [No Abstract] [Full Text] [Related]

  • 28. Pneumocystis jiroveci pneumonia.
    Luks AM, Neff MJ.
    Respir Care; 2007 Jan 15; 52(1):59-63. PubMed ID: 18330040
    [No Abstract] [Full Text] [Related]

  • 29. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A, Murri R, Ammassari A.
    AIDS; 1996 Aug 15; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract] [Full Text] [Related]

  • 30. Primary and secondary prophylaxis for Pneumocystis carinii related complications in HIV patients.
    Held M, Goebel FD.
    Eur Respir J; 1996 May 15; 9(5):868-71. PubMed ID: 8793444
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
    Crewe-Brown HH, Reyneke MP, Khoosal M, Becker PJ, Karstaedt AS.
    S Afr Med J; 2004 Jun 15; 94(6):440-2. PubMed ID: 15250455
    [No Abstract] [Full Text] [Related]

  • 33. Use of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia.
    Brun-Pascaud M, Fay M, Zhong M, Bauchet J, Dux-Guyot A, Pocidalo JJ.
    Antimicrob Agents Chemother; 1992 Feb 15; 36(2):470-2. PubMed ID: 1605613
    [Abstract] [Full Text] [Related]

  • 34. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody.
    Mori S, Imamura F, Kiyofuji C, Ito K, Koga Y, Honda I, Sugimoto M.
    Mod Rheumatol; 2006 Feb 15; 16(1):58-62. PubMed ID: 16622728
    [Abstract] [Full Text] [Related]

  • 35. Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Vananuvat P, Suwannalai P, Sungkanuparph S, Limsuwan T, Ngamjanyaporn P, Janwityanujit S.
    Semin Arthritis Rheum; 2011 Dec 15; 41(3):497-502. PubMed ID: 21959291
    [Abstract] [Full Text] [Related]

  • 36. Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.
    Perez-Ordoño L, Hoyo I, Sanclemente G, Ricart MJ, Cofan F, Perez-Villa F, de la Bellacasa JP, Moreno A, Cervera C.
    Transpl Infect Dis; 2014 Apr 15; 16(2):324-8. PubMed ID: 24456244
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Diagnosis and treatment of pneumocystis jirovecii pneumonia].
    Borde JP, Offensperger WB, de With K.
    Dtsch Med Wochenschr; 2011 Jul 15; 136(27):1426-30. PubMed ID: 21713721
    [No Abstract] [Full Text] [Related]

  • 39. The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis.
    Isidori A, Merli F, Angrilli F, Ferrara F, Alesiani F, Visani G.
    Leuk Lymphoma; 2011 Jan 15; 52(1):148-9. PubMed ID: 21067442
    [No Abstract] [Full Text] [Related]

  • 40. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP, McBride M.
    Int J STD AIDS; 2001 Feb 15; 12(2):126-7. PubMed ID: 11236102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.